Sleep Disturbance Clinical Trial
Official title:
Esketamine on Postoperative Sleep Disturbance of Patients Undergoing Spinal Surgery:A Randomized Controlled Trial
Verified date | June 2024 |
Source | Beijing Tiantan Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The goal of this clinical trial is to learn about the effect of intraoperative esketamine infusion on postoperative sleep disturbance(PSD) of patients undergoing spinal surgery. The main aims to answer are: - To explore the effect of intraoperative infusion of esketamine on the incidence of postoperative sleep disturbance and sleep quality in patients undergoing spinal surgery. - To explore the effect of intraoperative infusion of esketamine on postoperative pain, anxiety and depression ; Participants will be patients undergoing spinal surgery with general anesthesia at Beijing Tiantan Hospital. 0.3mg/kg/h esketamine or saline will be infused during surgery . The incidence of sleep disturbance , sleep quality, pain scores, hospital anxiety and depression scores and perioperative adverse events after surgery will be investigated.
Status | Recruiting |
Enrollment | 156 |
Est. completion date | January 28, 2026 |
Est. primary completion date | December 28, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - 18-65 years old, - American Society of Anesthesiologist (ASA) Physical Status classification I to III ; - Scheduled to undergo elective spinal surgery under general anesthesia ; - Signed informed consent ; Exclusion Criteria: - BMI > 35kg / m2 ; - Severe lesions of important organs and systems ; - Retained tracheal intubation or admitted to intensive care unit (ICU) postoperatively. - History of adverse reactions or contraindications to ketamine and esketamine ; - Cognitive dysfunction, communication disorders ; - Refused to participate in this study. |
Country | Name | City | State |
---|---|---|---|
China | Beijing Tian Tan Hospital | Beijing |
Lead Sponsor | Collaborator |
---|---|
Beijing Tiantan Hospital |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | The incidence of all drug-related adverse events | All drug-related adverse events including bradycardia, hypotension, tachycardia, hypertension, arrhythmia, nystagmus, hypersalivation, euphoria, emergence agitation, hallucinations, dreaminess and nightmares during surgery or before discharge.etc.Patients will be followed up for 3 days consecutively(at 8-10am). | within 72hours after surgery | |
Primary | The incidence of postoperative sleep disturbance(PSD) in patients undergoing spinal surgery | It will be evaluated by Athens Insomnia Scale (AIS) on the morning(8-10 am) of postoperative days 1-3, a score of 6 or higher will be defined as PSD. | during the first three days after surgery | |
Secondary | objective sleep quality(total sleep time) of patients with spinal surgery assesssed by the sleep monitoring equipment. | It will be evaluated by an sleep monitoring equipment which can record total sleep time in hour. | on the postoperative day 1 and postoperative day 3 after surgery | |
Secondary | The pain scores | Postoperative pain at rest and movement will be evaluated on the morning(8-10 am) of postoperative days 1-3 using NRS.0 indicating no pain, 10 indicating worst pain imaginable. | within 72hours after surgery | |
Secondary | dosage of analgesics | The analgesic consumption(PCIA) and supplemental analgesics within 72h will be recorded. | within 72 hours after surgery | |
Secondary | Postoperative hospital anxiety and depression scale ( HADS ) score. | Postoperative anxiety and depression scores will be measured by the Hospital Anxiety and Depression Scale, on the morning(8-10 am) of postoperative days (PODs) 1 and 3 , a score of 8 points or higher will be diagnosed as depression or anxiety. | on the postoperative day 1 and postoperative day 3 after surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04959214 -
The Effect Of Progressıve Relaxatıon Exercıses
|
N/A | |
Recruiting |
NCT05820919 -
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
|
N/A | |
Completed |
NCT05555186 -
The Effects of Bright Light Therapy on Adolescent's Sleep Quality and Well-being
|
N/A | |
Completed |
NCT05093465 -
A Comparison of Two Behavioral Sleep Interventions Among College Students (ProjectTECH)
|
N/A | |
Completed |
NCT03673397 -
The Acute Effect of Aerobic Exercise on Sleep in Patients With Depression
|
N/A | |
Recruiting |
NCT04368416 -
Anxiety/Depression, Sleep and Alcohol in Elderly Anxiety/Depression, Sleep Disturbances and Alcohol Use Disorder in Elderly With Cognitive Complaints
|
||
Completed |
NCT04566822 -
Calm Sleep Coaching
|
N/A | |
Not yet recruiting |
NCT06406309 -
Settling Down for Sleep in ADHD: The Impact of Sensory and Arousal Systems on Sleep in ADHD
|
N/A | |
Recruiting |
NCT00860756 -
Sleep Disturbance in Deployed Soldiers
|
Phase 0 | |
Recruiting |
NCT05699837 -
Alpha Entrainment for Pain and Sleep (Extension)
|
N/A | |
Completed |
NCT06108115 -
Smartphone-Based Intervention for Sleep Disturbance in Individuals Recovering From Alcohol Use Disorder
|
N/A | |
Completed |
NCT05511818 -
Radicle Rest: A Study of Cannabinoids on Sleep and Health Outcomes
|
N/A | |
Completed |
NCT04560595 -
Remote Guided Caffeine Reduction
|
N/A | |
Not yet recruiting |
NCT06104280 -
Medications for Opioid Use Disorder Photosensitive Retinal Ganglion Cell Function, Sleep, and Circadian Rhythms: Implications for Treatment
|
N/A | |
Enrolling by invitation |
NCT04290650 -
Sleep Disturbances in Patients With Psychotic Symptoms (AkuSleep)
|
N/A | |
Recruiting |
NCT04207502 -
Integrating Systematic Data of Geriatric Medicine to Explore the Solution for Health Aging
|
||
Suspended |
NCT03908905 -
Sleep Disturbances and Chronic Widespread Pain
|
||
Completed |
NCT03269760 -
Multimodal Sleep Pathway for Shoulder Arthroplasty
|
Phase 1 | |
Completed |
NCT04990206 -
Improving Sleep Health in Adults With Overweight or Obesity
|
N/A | |
Completed |
NCT03112824 -
Functional Assessment of Ashwagandaha Root Extract During Weight Loss
|
N/A |